Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTAA
1026
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
| $2.61M | ﹤0.01% |
258,719
-258,407
| -50% | -$2.59M |
|
1027
Huntington Bancshares
HBAN
$34.4B
| $2.59M | ﹤0.01% |
184,066
-807,754
| -81% | -$11.7M |
|
1028
Synchrony
SYF
$24.7B
| $2.57M | ﹤0.01% |
78,301
-92,899
| -54% | -$3.18M |
|
1029
National Health Investors
NHI
$3.73B
| $2.57M | ﹤0.01% |
49,142
-49,142
| -50% | -$2.69M |
|
|
FRC
1030
DELISTED
First Republic Bank
FRC
| $2.56M | ﹤0.01% |
20,981
-21,985
| -51% | -$2.68M |
|
1031
Evergy
EVRG
$19.1B
| $2.55M | ﹤0.01% |
40,589
-14,491
| -26% | -$870K |
|
1032
Jacobs Solutions
J
$16B
| $2.55M | ﹤0.01% |
25,721
-22,505
| -47% | -$2.21M |
|
|
STRE
1033
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
| $2.55M | ﹤0.01% |
252,755
-252,747
| -50% | -$2.53M |
|
|
SWSS
1034
DELISTED
Clean Energy Special Situations Corp. Common stock
SWSS
| $2.53M | ﹤0.01% |
500,000
-500,000
| -50% | -$2.51M |
|
1035
ICICI Bank
IBN
$108B
| $2.52M | ﹤0.01% |
115,310
+70,268
| +156% | +$1.57M |
|
1036
STAAR Surgical
STAA
$1.21B
| $2.51M | ﹤0.01% |
51,775
+29,911
| +137% | +$1.88M |
|
1037
Fortis
FTS
$29B
| $2.51M | ﹤0.01% |
62,707
-62,707
| -50% | -$2.46M |
|
1038
Cameco
CCJ
$37.5B
| $2.5M | ﹤0.01% |
110,412
-125,736
| -53% | -$2.96M |
|
|
HWKZ
1039
DELISTED
Hawks Acquisition Corp
HWKZ
| $2.5M | ﹤0.01% |
250,000
-250,000
| -50% | -$2.47M |
|
1040
Maravai LifeSciences
MRVI
$966M
| $2.5M | ﹤0.01% |
174,421
-200,253
| -53% | -$3.15M |
|
|
JWSM
1041
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
| $2.49M | ﹤0.01% |
246,462
-246,464
| -50% | -$2.47M |
|
1042
Best Buy
BBY
$18.2B
| $2.47M | ﹤0.01% |
30,851
-30,399
| -50% | -$2.24M |
|
|
EAC
1043
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
| $2.47M | ﹤0.01% |
245,054
+177,946
| +265% | +$1.78M |
|
1044
Qualys
QLYS
$5.1B
| $2.46M | ﹤0.01% |
21,882
-19,692
| -47% | -$2.46M |
|
1045
Principal Financial Group
PFG
$24.3B
| $2.44M | ﹤0.01% |
29,072
-20,814
| -42% | -$1.79M |
|
1046
Stanley Black & Decker
SWK
$14.3B
| $2.43M | ﹤0.01% |
32,326
-8,126
| -20% | -$634K |
|
1047
Mid-America Apartment Communities
MAA
$15.5B
| $2.43M | ﹤0.01% |
15,455
-15,457
| -50% | -$2.41M |
|
1048
Restaurant Brands International
QSR
$25.7B
| $2.42M | ﹤0.01% |
37,497
-37,497
| -50% | -$2.3M |
|
1049
Lennar Class A
LEN
$19.9B
| $2.42M | ﹤0.01% |
27,622
-31,141
| -53% | -$2.52M |
|
1050
F5
FFIV
$22.9B
| $2.39M | ﹤0.01% |
16,633
-262,019
| -94% | -$38.4M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.